SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

3 weeks ago

NEW YORK, Oct. 22, 2024 ( GLOBE NEWSWIRE ) -- SIGA Technologies, Inc. ( SIGA ) ( NASDAQ: SIGA ) , a commercial-stage pharmaceutical company and leader in infectious diseases, today announced that it entered into an agreement with Vanderbilt University to obtain a license to a portfolio of ...

Ticker	Sentiment	Impact
SIGA	Neutral	59 %